KOHJIN BIO CO LTD (177A.T)
JPY 1703.0
(-0.12%)
JPY 1703.0
(-0.12%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 683.01 Million JPY | -38.06% |
| 2022 | 1.1 Billion JPY | 111.75% |
| 2021 | 520.73 Million JPY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 683.01 Million JPY | -38.06% |
| 2023 Q4 | 683.01 Million JPY | 10.23% |
| 2023 Q3 | 619.61 Million JPY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| PRISM BioLab Co.,LTD | 17.92 Million JPY | -3709.526% |
| GNI Group Ltd. | 2.33 Billion JPY | 70.694% |
| Linical Co., Ltd. | - JPY | -Infinity% |
| Trans Genic Inc. | 2.22 Billion JPY | 69.34% |
| MEDINET Co., Ltd. | 67.48 Million JPY | -912.152% |
| Soiken Holdings Inc. | 1.12 Billion JPY | 39.064% |
| Cytori Cell Research Institute, Inc. | 103.53 Million JPY | -559.696% |
| AnGes, Inc. | 1.61 Billion JPY | 57.73% |
| OncoTherapy Science, Inc. | 73.99 Million JPY | -822.999% |
| Nxera Pharma Co., Ltd. | 2.9 Billion JPY | 76.472% |
| Immuno-Biological Laboratories Co., Ltd. | 321.91 Million JPY | -112.172% |
| NanoCarrier Co., Ltd. | 184 Thousand JPY | -371101.087% |
| Carna Biosciences, Inc. | 140.14 Million JPY | -387.377% |
| CanBas Co., Ltd. | 728 Thousand JPY | -93720.055% |
| D. Western Therapeutics Institute, Inc. | 87.86 Million JPY | -677.358% |
| RaQualia Pharma Inc. | 147.93 Million JPY | -361.684% |
| Chiome Bioscience Inc. | 64.1 Million JPY | -965.422% |
| Kidswell Bio Corporation | 875.65 Million JPY | 22.0% |
| PeptiDream Inc. | 2.4 Billion JPY | 71.59% |
| Oncolys BioPharma Inc. | 5.34 Million JPY | -12685.661% |
| Ribomic Inc. | 2.27 Million JPY | -29935.62% |
| SanBio Company Limited | - JPY | -Infinity% |
| Healios K.K. | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 1.00 JPY | -68300999900.0% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 36 Million JPY | -1797.25% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | 29 Million JPY | -2255.207% |
| CellSource Co., Ltd. | 305.92 Million JPY | -123.261% |
| FunPep Company Limited | 25.54 Million JPY | -2574.171% |
| Kringle Pharma, Inc. | 364.05 Million JPY | -87.611% |
| Stella Pharma Corporation | 1.11 Billion JPY | 38.812% |
| TMS Co., Ltd. | 50.02 Million JPY | -1265.337% |
| Noile-Immune Biotech Inc. | 20.9 Million JPY | -3167.834% |
| Cuorips Inc. | 1.04 Million JPY | -65385.139% |
| K Pharma,Inc. | 10.79 Million JPY | -6227.682% |
| Takara Bio Inc. | 11.85 Billion JPY | 94.236% |
| ReproCELL Incorporated | 248.14 Million JPY | -175.252% |
| PhoenixBio Co., Ltd. | 450.58 Million JPY | -51.582% |
| StemCell Institute Inc. | 42.26 Million JPY | -1516.133% |
| Japan Tissue Engineering Co., Ltd. | 228.56 Million JPY | -198.825% |
| CellSeed Inc. | 46.19 Million JPY | -1378.665% |